Search research articles
Contact Us
Filters
Showing results (201-210 of 230) with videos related to
Page
of 23
Sort By:
Bordeaux Medical
|
January 1, 1970
[Hodgkin's disease revealed by intracranial localization]
H Léger, H Pouyanne, P Léman, et al.
Cancer
|
May 15, 1988
Non-Hodgkin's malignant lymphomas in patients older than 80. 70 cases
B Hoerni, J J Sotto, H Eghbali, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|
July 10, 1970
[Hazards of administering vitamin B12 to cancer patients]
J Chauvergne, B Hoerni, A Hugues, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1987
Distinct entities among low-grade non-Hodgkin's malignant lymphomas. Analysis of a series of 377 cases
B Hoerni, M Trojani, H Eghbali, et al.
Bulletin Du Cancer
|
October 1, 1994
[Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases]
H Eghbali, C Pétorin, I de Mascarel, et al.
Bulletin Du Cancer
|
January 1, 1988
[New combination of epirubicine, bleomycin, vinblastine and prednisone (EBVP II) before radiotherapy in localized stages of Hodgkin's disease. Phase II trial in 50 patients]
B Hoerni, M B Orgerie, H Eghbali, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1978
BCG in the immunotherapy of non-Hodgkin's malignant lymphomas: preliminary results of a controlled trial
B Hoerni, M Durand, A de Mascarel, et al.
British Journal of Haematology
|
August 1, 1979
Successful maintenance immunotherapy by BCG of non-Hodgkin's malignant lymphomas: results of a controlled trial
B Hoerni, M Durand, P Richaud, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1991
Novel combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP II) before radical radiotherapy in localized stages (I-IIIA) of Hodgkin's disease. Early results in 100 consecutive patients. Pierre-et-Marie-Curie Group
B Hoerni, M B Orgerie, H Eghbali, et al.
Bulletin Du Cancer
|
January 1, 1987
[The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials]
R Zittoun, H Eghbali, A Audebert, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 230) with videos related to
Sort By:
Page
of 23
Bordeaux Medical
|
January 1, 1970
[Hodgkin's disease revealed by intracranial localization]
H Léger, H Pouyanne, P Léman, et al.
Cancer
|
May 15, 1988
Non-Hodgkin's malignant lymphomas in patients older than 80. 70 cases
B Hoerni, J J Sotto, H Eghbali, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|
July 10, 1970
[Hazards of administering vitamin B12 to cancer patients]
J Chauvergne, B Hoerni, A Hugues, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1987
Distinct entities among low-grade non-Hodgkin's malignant lymphomas. Analysis of a series of 377 cases
B Hoerni, M Trojani, H Eghbali, et al.
Bulletin Du Cancer
|
October 1, 1994
[Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases]
H Eghbali, C Pétorin, I de Mascarel, et al.
Bulletin Du Cancer
|
January 1, 1988
[New combination of epirubicine, bleomycin, vinblastine and prednisone (EBVP II) before radiotherapy in localized stages of Hodgkin's disease. Phase II trial in 50 patients]
B Hoerni, M B Orgerie, H Eghbali, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1978
BCG in the immunotherapy of non-Hodgkin's malignant lymphomas: preliminary results of a controlled trial
B Hoerni, M Durand, A de Mascarel, et al.
British Journal of Haematology
|
August 1, 1979
Successful maintenance immunotherapy by BCG of non-Hodgkin's malignant lymphomas: results of a controlled trial
B Hoerni, M Durand, P Richaud, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1991
Novel combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP II) before radical radiotherapy in localized stages (I-IIIA) of Hodgkin's disease. Early results in 100 consecutive patients. Pierre-et-Marie-Curie Group
B Hoerni, M B Orgerie, H Eghbali, et al.
Bulletin Du Cancer
|
January 1, 1987
[The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials]
R Zittoun, H Eghbali, A Audebert, et al.
Page
of 23